An interesting study found that cotreatment with erastin and docetaxel significantly decreased cell viability, promoted cell apoptosis and induced cell cycle arrest at the G2/M stage in docetaxel-resistant ovarian cancer (A2780/Taxol) cells (which overexpress the ABCB1 protein). Here, ABCB1 is linked to ovarian carcinoma.